These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21949239)

  • 1. Myotonic dystrophy protein kinase is critical for nuclear envelope integrity.
    Harmon EB; Harmon ML; Larsen TD; Yang J; Glasford JW; Perryman MB
    J Biol Chem; 2011 Nov; 286(46):40296-306. PubMed ID: 21949239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myotonic dystrophy and myotonic dystrophy protein kinase.
    Ueda H; Ohno S; Kobayashi T
    Prog Histochem Cytochem; 2000; 35(3):187-251. PubMed ID: 11064921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD.
    Amack JD; Reagan SR; Mahadevan MS
    J Cell Biol; 2002 Nov; 159(3):419-29. PubMed ID: 12427866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts.
    Furling D; Lemieux D; Taneja K; Puymirat J
    Neuromuscul Disord; 2001 Nov; 11(8):728-35. PubMed ID: 11595515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1.
    Kaliman P; Llagostera E
    Cell Signal; 2008 Nov; 20(11):1935-41. PubMed ID: 18583094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts.
    Langlois MA; Lee NS; Rossi JJ; Puymirat J
    Mol Ther; 2003 May; 7(5 Pt 1):670-80. PubMed ID: 12718910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.
    Furling D; Lam le T; Agbulut O; Butler-Browne GS; Morris GE
    Am J Pathol; 2003 Mar; 162(3):1001-9. PubMed ID: 12598332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of DMPK: correlation with CTG repeat expansion and fibre type composition in myotonic dystrophy type 1.
    Salvatori S; Fanin M; Trevisan CP; Furlan S; Reddy S; Nagy JI; Angelini C
    Neurol Sci; 2005 Oct; 26(4):235-42. PubMed ID: 16193250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy.
    Orengo JP; Chambon P; Metzger D; Mosier DR; Snipes GJ; Cooper TA
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2646-51. PubMed ID: 18272483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy.
    Winchester CL; Ferrier RK; Sermoni A; Clark BJ; Johnson KJ
    Hum Mol Genet; 1999 Mar; 8(3):481-92. PubMed ID: 9949207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myotonic dystrophy protein kinase is expressed in embryonic myocytes and is required for myotube formation.
    Harmon EB; Harmon ML; Larsen TD; Paulson AF; Perryman MB
    Dev Dyn; 2008 Sep; 237(9):2353-66. PubMed ID: 18729234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model.
    Amack JD; Paguio AP; Mahadevan MS
    Hum Mol Genet; 1999 Oct; 8(11):1975-84. PubMed ID: 10484765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for PLCβ1 in myotonic dystrophies type 1 and 2.
    Faenza I; Blalock W; Bavelloni A; Schoser B; Fiume R; Pacella S; Piazzi M; D'Angelo A; Cocco L
    FASEB J; 2012 Jul; 26(7):3042-8. PubMed ID: 22459146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered nuclear structure in myotonic dystrophy type 1-derived fibroblasts.
    Rodríguez R; Hernández-Hernández O; Magaña JJ; González-Ramírez R; García-López ES; Cisneros B
    Mol Biol Rep; 2015 Feb; 42(2):479-88. PubMed ID: 25307018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometry analysis of complexes formed by myotonic dystrophy protein kinase (DMPK).
    Forner F; Furlan S; Salvatori S
    Biochim Biophys Acta; 2010 Jun; 1804(6):1334-41. PubMed ID: 20188867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear Envelope Alterations in Myotonic Dystrophy Type 1 Patient-Derived Fibroblasts.
    Viegas D; Pereira CD; Martins F; Mateus T; da Cruz E Silva OAB; Herdeiro MT; Rebelo S
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
    Ranum LP; Day JW
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myotonic dystrophy protein kinase (DMPK) gene expression in lymphocytes of patients with myotonic dystrophy.
    Depardon F; Cisneros B; Alonso-Vilatela E; Montañez C
    Arch Med Res; 2001; 32(2):123-8. PubMed ID: 11343809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase.
    Mounsey JP; Mistry DJ; Ai CW; Reddy S; Moorman JR
    Hum Mol Genet; 2000 Sep; 9(15):2313-20. PubMed ID: 11001935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of myotonic dystrophy protein kinase (DMPK) mRNA as a result of a triplet repeat expansion in myotonic dystrophy.
    Carango P; Noble JE; Marks HG; Funanage VL
    Genomics; 1993 Nov; 18(2):340-8. PubMed ID: 8288237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.